Induced sputum in children and adolescents with asthma: Safety, clinical applicability and inflammatory cells aspects in stable patients and during exacerbation

Jornal de Pediatria

Volumn 81, Issue 3, 2005, Pages 216-224

  Palomino, Addy L M ^a   Bussamra, Maria Helena C F ^a,b   Saraiva Romanholo, Beatriz M ^a   Martins, Milton A ^a   Nunes, Maria Do Patrocínio T ^a   Rodrigues, Joaquim C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FMUSP ^*  (Brazil)

Author keywords

Asthma; Children; Sputum cell count

Indexed keywords

IMMUNOGLOBULIN E; SODIUM CHLORIDE; BRONCHODILATING AGENT; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS OBSTRUCTION; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; NEUTROPHIL; PREVALENCE; SAFETY; SPIROMETRY; SPUTUM; BLOOD; CELL COUNT; CROSS-SECTIONAL STUDY; CYTOLOGY; FEMALE; HOSPITALIZATION; INHALATION TEST; MALE; METHODOLOGY; REPRODUCIBILITY;

ADOLESCENT; ALBUTEROL; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CELL COUNT; CHILD; CROSS-SECTIONAL STUDIES; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; MALE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SPUTUM;

EID: 28344452677     PISSN: 00217557     EISSN: 00217557     Source Type: Journal    
DOI: 10.2223/1342     Document Type: Article

References (34)

1. NHLBI/WHO. Global strategy for asthma management and prevention. In: Lenfant C. Global Initiative for Asthma. Bethesda: National Institute of Health. National Heart, Lung and Blood Institute; 2002.
2. Sampson AP. Eosinophils: provokers or bystanders in asthma? Clin Exp Allergy Rev. 2001;1:73-6.
3. Vignola AM, La Grutta S, Chiappara G, Benkeder A, Bellia V, Bonsignore G. Cellular network in airways inflammation and remodelling. Pediatr Respir Rev. 2002;3:41-6.
4. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47:25-9.
5. Wilson NM, James A, Uasul C, Payne DN, Hablas H, Agrofioti C, et al. Asthma severity and inflammations markers in children. Pediatr Allergy Immunol. 2001;12:125-32.
6. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107-36.
7. Polgar G, Promadhat V. Pulmonary function testing in children. Philadelphia: WB Saunders; 1971. p. 273.
8. Rodrigues JC, Cardieri JMA, Bussamra MHCF, Nakaie CMA, Almeida MB, Silva Filho LVF, et al. Provas de função pulmonar em crianças e adolescentes. J Pneumol. 2002;28(Suppl 3): S207-21.
9. Pizzichini MMM. O exame do escarro como instrumento responsivo e adequado para investigar o efeito de drogas na inflamação das vias aéreas [tese]. São Paulo: Faculdade de Medicina da Universidade Federal de São Paulo; 1997.
10. Pizzichini MMM, Popov TA, Efthimiadis A, Hussack P, Evans S, Pizzichini E, et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996;154:866-9.
11. Saraiva-Romanholo BM, Barnabe V, Carvalho AL, Martins MA, Saldiva PH, Nunes MP. Comparison of three methods for differential cell count in induced sputum. Chest. 2003;124:1060-6.
12. Wilson NM, Bridge P, Spanevello A, Silverman M. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax. 2000;55:768-74.
13. Cai Y, Carty K, Henry RL, Gibson PG. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children. Eur Respir J. 1998;11:848-53.
14. Grootendorst DC, van den Bos JW, Romeijn JJ, Veselic Charvat M, Duiverman EJ, Vrijlandt E, et al. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity. Eur Respir J. 1999;13:647-53.
15. Paggiaro PL, and the members of the working group 1. Sputum induction. Eur Respir J. 2002;20(Suppl. 37):S3-8.
16. Popov TA, Pizzichini MMM, Pizzichini E, Kolendowicz R, Punthakee Z, Dolovich J, et al. Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J. 1995;8:559-65.
17. Twaddell SH, Gibson PG, Carty K, Woolley KL, Henry RL. Assessment of airway inflammation in children with acute asthma using induced sputum. Eur Respir J. 1996;9:2104-08.
18. Pizzichini MMM, Pizzichini E, Clelland L, Efthmiadis A, Mahony J, Dolovich J, et al. Sputum in severe exacerbations of asthma, kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med. 1997;155:1501-6.
19. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack EM, Chinchilli VM, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med. 2001;163:1470-5.
20. Holz O, Kips J, Magnussen H. Update on sputum methodology. Eur Respir J. 2000;16:355-9.
21. Gershman NH, Liu H, Wong HH, Liu J, Fahy JV. Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol. 1999;104:322-32.
22. Efthimiadis A, Jayaram L, Weston S, Carruthers S, Hargreave FE. Induced sputum: time from expectoration to processing. Eur Respir J. 2002;19:706-8.
23. Gershman NH, Wong HH, Liu JT, Mahlmeister MJ, Fahy JV. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur Respir J. 1996;9:2448-53.
24. Efthimiadis A, Spanevello A, Hammid Q, Kelly MM, Linden M, Louis R et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J. 2002;20(Suppl. 37):S19-S23.
25. Cai Y, Carty K, Henry RL, Gibson PG. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children. Eur Respir J. 1998;11:848-53.
26. Gibson PG, Norzila MZ, Fakes K, Simpson J, Henry RL. Pattern of airway inflammation and Its determinants in children with acute severe asthma. Pediatr Pulmonol. 1999;28:261-70.
27. Pavord ID. And the members of the Working Group 5. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J. 2002;20(Suppl.):S40-3.
28. Gibson PG. Use of induced sputum to examine airway inflammation in childhood asthma. J Allergy Clin Immunol. 1998;102(Suppl.):S100-1.
29. Green RH, Brightling CE, McKenna S. asthma Exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet. 2002;360:1715-21.
30. Pedersen S. Why does airway inflammation persist? Is it failure to treat early? Am J Respir Crit Care Med. 2000;161(Suppl.): S182-5.
31. Bartoli ML, Bacci E, Carnevali S, Cianchetti S, Dente FL, Di Franco A, et al. Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation. Respir Med. 2004;98:184-93.
32. Fuhlbrigge AL. Asthma severity and asthma control: symptoms, pulmonary function, and inflammatory markers. Curr Opin Pulm Med. 2004;10:1-6.
33. Sterk PJ, Hargreave FE, Kips JC, Inman MD, Louis R, Pizzichini MMM, et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J. 2002;20(Suppl.):S40-3.
34. Gibson PG, Simpson JL, Hankin R, Powel H, Henry RL. Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax. 2003;58:116-21.